Court approves pSvida re-incorporation

By Dylan Bushell-Embling
Wednesday, 11 June, 2008

WA biotech pSvida (ASX: PSD) has received court approval to re-incorporate in the US, paving the way for the company to be re-listed on the NASDAQ stock exchange.

The company announced yesterday that the Federal Court of Australia had approved its reincorporation proposals.

The reincorporation will take effect today, and pSvida shares will start trading on NASDAQ starting today or Thursday.

As part of the process, pSvida will cease trading shares on the ASX, and won't resume full ASX trading until June 26.

pSvida will also begin trading on the Frankfurt Stock Exchange on Thursday.

Related News

Hormone therapy shifts body proteins to match gender identity

Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...

Targeting 'molecular bodyguards' weakens prostate cancer cells

Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...

Females found to carry a higher genetic risk of depression

An international team of scientists has discovered about twice as many genetic 'flags'...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd